![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, January 12, 2019 3:56:47 PM
Be careful investors, do your research, take a closer look. Agios is a company involved in developing biologic drugs.....the CSO of Agios is a chemist..... the person holding such a position is supposed to be a biologist, someone with a background in biology, not small molecule drugs.
The truth is the CSO has no experience in his background to make him suitable for such a position.....
Recent AGIO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:29:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:22:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:20:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:19:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:18:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:15:52 PM
- Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress • GlobeNewswire Inc. • 06/15/2024 12:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:25:21 PM
- Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET • GlobeNewswire Inc. • 06/06/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/05/2024 11:50:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:14:51 PM
- Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia • GlobeNewswire Inc. • 06/03/2024 10:30:00 AM
- Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 • GlobeNewswire Inc. • 05/30/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 11:09:32 AM
- Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty • GlobeNewswire Inc. • 05/28/2024 11:00:00 AM
- Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress • GlobeNewswire Inc. • 05/14/2024 02:00:00 PM
- Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024 • GlobeNewswire Inc. • 05/06/2024 11:00:00 AM
- Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024 • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- Agios Reports Business Highlights and First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024 • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
- Agios Publishes 2024 Environmental, Social and Governance (ESG) Report • GlobeNewswire Inc. • 04/09/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:47:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:20:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:18:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:15:23 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM